1
                                                                    Exhibit 99.2

[IMS HEALTH LOGO]                                                [TRIZETTO LOGO]

                                      News
                              For Immediate Release

Contact: Michael Gury                         Jodi Amendola
         IMS HEALTH Communications            TriZetto Communications
         (203) 222-4230                       (480) 657-9966


         Jack Walsh                           Ethan Denkensohn
         IMS HEALTH Investor Relations        TriZetto Investor Relations
         (203) 222-4250                       (212) 213-0006



                IMS HEALTH AND TRIZETTO IN DISCUSSIONS REGARDING
                            TRANSACTION ALTERNATIVES


WESTPORT, CT, April 18, 2000 - IMS HEALTH (NYSE:RX) and The TriZetto Group, Inc.
(NASDAQ:TZIX) today jointly announced that they are in discussions regarding
transaction structure options. In a pro-active move designed to be responsive to
shareholders, the two companies are evaluating potential alternatives. TriZetto
is a leading provider of vertical, Internet-enabled application services and
business portals to the healthcare industry. IMS HEALTH is the world's leading
provider of information solutions to the pharmaceutical and healthcare
industries.

         There can be no assurance that any development or definitive agreement
will materialize as a result of these discussions. IMS HEALTH and TriZetto do
not expect to make any further announcements about alternatives unless and until
a definitive agreement is reached.

                                      # # #

April 18, 2000

This press release may contain forward-looking information (statements that are
not historical facts and relate to future performance) that involves risks and
uncertainties. The forward-looking statements
   2
are made pursuant to the Safe Harbor provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements may include
statements about future net revenues, profits, and financial results, the market
for TriZetto's services, future service offerings, client and partner
relationships, and TriZetto's operational capabilities. Actual results may
differ materially from those stated in any forward-looking statements based on a
number of factors, including the effectiveness of TriZetto's implementation of
its business plan, the market's acceptance of TriZetto's services, risks
associated with management of growth, reliance on third parties to supply key
components of TriZetto's services, attraction and retention of employees,
variability of quarterly operating results, including the effects of the client
purchasing patterns due to Year 2000 issues, competitive factors, risks
associated with acquisitions, changes in demand for third party products or
solutions, which form the basis of TriZetto's service offerings, and risks
associated with rapidly changing technology, as well as the risks identified in
TriZetto's SEC filings, including information under the heading of risk factors
in its Form S-1 filed in October 1999.

This press release includes statements which may constitute forward-looking
statements made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Although IMS HEALTH believes the expectations
contained in such forward-looking statements are reasonable, it can give no
assurance that such expectations will prove correct. This information may
involve risks and uncertainties that could cause actual results of IMS HEALTH to
differ materially from the forward-looking statements. Factors which could cause
or contribute to such differences include, but are not limited to (i) the risks
associated with operating on a global basis, including fluctuations in the value
of foreign currencies relative to the U.S. dollar, and the ability to
successfully hedge such risks, (ii) to the extent IMS HEALTH seeks growth
through acquisitions and joint ventures, the ability to identify, consummate and
integrate acquisitions and ventures on satisfactory terms, (iii) the ability to
develop new or advanced technologies and systems for its businesses on time and
on a cost-effective basis, (iv) regulatory, legislative and enforcement
initiatives, particularly in the areas of medical privacy and tax, and (v)
deterioration in economic conditions, particularly in the pharmaceutical,
healthcare or other industries in which IMS HEALTH's customers operate.
Additional information on factors that may affect the business and financial
results of the Company can be found in filings of the Company made from time to
time with the Securities and Exchange Commission.